| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.aurolabs.com | |
| Market Cap | 52.81 Cr. | |
| Enterprise Value(EV) | 56.55 Cr. | 2023-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 3.92 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 21.63 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 33.51 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 54.87 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 1.54 | Calculated using Price: 84.73 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.62 Cr. | 6,232,500 Shares |
| FaceValue | 10 | |
| About Auro Laboratories Ltd. | ||
| Auro Laboratories incorporated in 1989 is engaged in business of manufacturing active pharmaceutical ingredients (API's), intermediates and generic formulations. The company is promoted by Shri Sharat Deorah and Shri Satish Deorah. | ||
| 1 Day |
|
-2.44% |
| 1 Week |
|
+0.02% |
| 1 Month |
|
+29.16% |
| 3 Month |
|
+30.23% |
| 6 Month |
|
+11.90% |
| 1 Year |
|
-5.68% |
| 2 Year |
|
-20.18% |
| 5 Year |
|
+6.34% |
| 10 Year |
|
+912.56% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 8.76 | 11.01 | 10.83 | 9.06 | 31.53 | 28.95 | 20.84 | 28.67 | 9.47 | |
| Return on Capital Employed (%) | 9.40 | 10.76 | 11.21 | 20.24 | 28.65 | 29.12 | 24.80 | 38.88 | 12.20 | |
| Return on Assets (%) | 2.04 | 2.89 | 3.24 | 3.11 | 12.34 | 13.78 | 12.32 | 19.34 | 5.87 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
| Shh. Funds | 7 | 8 | 9 | 9 | 13 | 17 | 22 | 29 | 32 | 34 | |
| Non Curr. Liab. | 7 | 8 | 7 | 11 | 8 | 6 | 5 | 4 | 3 | 4 | |
| Curr. Liab. | 13 | 14 | 10 | 6 | 10 | 10 | 6 | 9 | 20 | 18 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 27 | 29 | 26 | 27 | 30 | 33 | 32 | 42 | 55 | 56 | |
| Non Curr. Assets | 11 | 11 | 13 | 13 | 15 | 15 | 14 | 14 | 18 | 20 | |
| Curr. Assets | 16 | 18 | 12 | 14 | 16 | 19 | 18 | 28 | 37 | 36 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 27 | 29 | 26 | 27 | 30 | 33 | 32 | 42 | 55 | 56 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
| Net Sales | 34 | 33 | 28 | 35 | 41 | 47 | 44 | 54 | 51 | 53 | |
| Other Income | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Total Income | 34 | 33 | 28 | 36 | 41 | 48 | 45 | 55 | 52 | 54 | |
| Total Expenditure | -31 | -30 | -25 | -31 | -34 | -40 | -38 | -43 | -46 | -49 | |
| PBIDT | 3 | 3 | 3 | 5 | 7 | 8 | 7 | 12 | 6 | 5 | |
| Interest | -2 | -2 | -2 | -1 | -1 | -1 | -1 | 0 | -1 | -1 | |
| Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
| Taxation | -2 | -1 | -2 | -2 | -3 | -1 | -1 | ||||
| Exceptional Items | |||||||||||
| PAT | 1 | 1 | 1 | 1 | 4 | 4 | 4 | 7 | 3 | 2 | |
| Adjusted EPS | 1 | 1 | 1 | 1 | 6 | 7 | 7 | 12 | 5 | 4 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 1 | 4 | -1 | 8 | 6 | 5 | 7 | 9 | 13 | -7 | |
| Cash Fr. Inv. | -1 | -1 | -1 | -2 | -2 | -2 | -3 | -2 | -4 | -5 | |
| Cash Fr. Finan. | -1 | -3 | 1 | -5 | -4 | -2 | -2 | -6 | 0 | 10 | |
| Net Change | 0 | 1 | -1 | 0 | 0 | 1 | 2 | 2 | 9 | -2 | |
| Cash & Cash Eqvt | 0 | 1 | 0 | 1 | 1 | 2 | 4 | 6 | 15 | 12 |
|
Mon, 29 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance In terms of Regulation 24A of SEBI [Listing Obligations and Disclosure Requirements] Regulation 2015 (Listing Regulations) read with Clause 3(b)(iii) of the above referred SEBI Circular we are submitting the Annual Secretarial Compliance Report of the Company for the year ended March 31 2023 issued by M/s. GMJ & Associates Practicing Company Secretaries enclosed hereunder. |
|
Wed, 17 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication With reference to Regulation 47 of SEBI [Listing Obligations and Disclosure Requirements] Regulation 2015 (Listing Regulations) we are enclosing herewith copies of Newspaper advertisement of Audited Standalone Financial Results of the Company for the quarter and year ended March 31 2023 published in the following Newspapers:1. Mumbai Lakshdeep (i.e. Marathi newspaper) dated May 17 2023.2. Active Times (i.e. English Newspaper) dated May 17 2023 |
|
Tue, 16 May 2023
Results - Financial Results Dated 16/05/2023 Pursuant to Regulation 30 & Regulation 33 of SEBI (LODR) Regulations 2015 we wish to inform you that the Board of Directors of the Company at their Meeting held today (i.e. Tuesday May 16 2023) has transacted the following business:1. Approved the Audited Financial Results of the Company for the quarter and year ended March 31 2023 as recommended by the Audit Committee.In this regard we are enclosing herewith: Audited Financial Results for the quarter and year ended March 31 2023 along with the Statement of Assets and Liabilities of the Company and Cash Flow Statement as on that date. Auditors Report on the Financial Results for the quarter & year ended March 31 2023. Declaration regarding Auditor Report with unmodified opinion on the Audited Standalone Financial Results of the Company for the Financial Year ended on March 31 2023. |
| Mon, 05 Jun 2023 |
Closing Below Previous Low
|
Close Within 52 Week High Zone
|
High Increase in 1 Month
|
High Increase in 3 Months
|
William %R Trending Down
|
Equities
M.F.
Sectors
StockEdge Social